Tenderwize
Back to tender search

Omalizumab Discount Agreement Open House

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 30, 2028 · 681 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 18 Omalizumab

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

No indication of estimated contract value or expected volume; revenue depends on actual prescriptions and number of par...

The notice explicitly states this is not a public procurement under EU directives; legal remedies lie with social court...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Conclusion of discount agreements (Rabattverträge) for the active substance Omalizumab
  • Standardized contract terms no individualized negotiations
Show full summary

Open house procedure by Techniker Krankenkasse (TK) for discount agreements (Rabattverträge) on the active substance Omalizumab. The procedure allows any qualified pharmaceutical entrepreneur to join at any time during the contract term (max 24 months until 30.06.2028). No exclusivity, no individual negotiations, and no estimated value provided. Eligibility requires being a pharmaceutical entrepreneur with a valid marketing authorization for the product. Award criteria are not specified. Submission is via email (with qualified electronic signature) or postal mail. Important: This is not a public procurement in the traditional sense; legal remedies lie with social courts, not procurement chambers.

Risks

No indication of estimated contract value or expected volume; revenue depends on actual prescriptions and number of par...

The notice explicitly states this is not a public procurement under EU directives; legal remedies lie with social court...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur under § 4 Abs. 18 AMG with a valid marketing authorization for Omalizumab

Eligibility

  • Must submit a self-declaration (Anlage 4) confirming eligibility and reliability

Administrative

  • Contract can be signed at any time during the term but for timely inclusion in pharmacy software documents must be received by the 3rd of the previous month

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; the procedure is open to all qualified participants with standardized conditions.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Omalizumab Discount Agreement Open House

Single lot covering all discount agreements for Omalizumab. The TK aims to conclude rebate contracts with all eligible pharmaceutical entrepreneurs under § 130a Abs. 8 SGB V.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2026 - Jun 2028

Category

Pharmaceutical products

Award Criteria

No award criteria specified; the procedure is open to all qualified participants with standardized conditions.

Deadline

Deadline Jun 30, 2028

Procurement Details

Publication date
20 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
349347-2026

Documents (1)

Similar tenders